JOURNAL OF PHARMACEUTICAL INNOVATION, cilt.17, sa.2, ss.510-520, 2022 (SCI-Expanded)
Purpose This study aimed to prepare a suitable formulation and perform in vitro characterization studies for oral use by exploiting the synergistic effect of alpha-lipoic acid (ALA) and cyanocobalamin (Vit B-12) for the treatment and prophylaxis of various diseases such as diabetic neuropathy, peripheral neuropathy, and neurological disorders.